|
1
|
Barbui T, Tefferi A, Vannucchi AM,
Passamonti F, Silver RT, Hoffman R, Verstovsek S, Mesa R, Kiladjian
JJ, Hehlmann R, et al: Philadelphia chromosome-negative classical
myeloproliferative neoplasms: Revised management recommendations
from European LeukemiaNet. Leukemia. 32:1057–1069. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Arber DA, Orazi A, Hasserjian R, Thiele J,
Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M and Vardiman JW:
The 2016 revision to the World Health Organization classification
of myeloid neoplasms and acute leukemia. Blood. 127:2391–2405.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ongenae K, Janssens A, Noens L, Wieme N,
Geerts ML, Beele H and Naeyaert JM: Erythromelalgia: A clue to the
diagnosis of polycythemia vera. Dermatology. 192:408–410.
1996.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Corredoira Sánchez JC, González López M,
Cortés Laiño JA, Gomara García S, Pérez Alvarez R, Casariego Vales
B, López Alvarez MJ and García Rodríguez JF: Neurologic
manifestations of polycythemia vera. Analysis of 24 cases and
review of the literature. An Med Interna. 7:67–70. 1990.PubMed/NCBI(In Spanish).
|
|
5
|
Torgano G, Mandelli C, Massaro P, Abbiati
C, Ponzetto A, Bertinieri G, Bogetto SF, Terruzzi E and de Franchis
R: Gastroduodenal lesions in polycythaemia vera: Frequency and role
of Helicobacter pylori. Br J Haematol. 117:198–202. 2002.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lelonek E, Matusiak L, Wrobel T and
Szepietowski JC: Aquagenic pruritus in polycythemia vera: Clinical
characteristics. Acta Derm Venereol. 98:496–500. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ong E, Barraco F, Nighoghossian N, Praire
A, Desestret V, Derex L, Vighetto A and Biotti D: Cerebrovascular
events as presenting manifestations of Myeloproliferative Neoplasm.
Rev Neurol (Paris). 172:703–708. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Akdi A, Ozeke O, Karanfil M, Ertem AG,
Yayla C, Demirtas K, Guney T, Unal S and Selcuk MT: Diurnal rhythm
of blood pressure in patients with polycythemia vera. Blood Press
Monit. 25:69–74. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Venton G, Turcanu M, Colle J, Thuny F,
Chebrek S, Farnault L, Mercier C, Ivanov V, Fanciullino R, Suchon
P, et al: Pulmonary hypertension in patients with
myeloproliferative neoplasms: A large cohort of 183 patients. Eur J
Intern Med. 68:71–75. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rossi C, Randi ML, Zerbinati P, Rinaldi V
and Girolami A: Acute coronary disease in essential thrombocythemia
and polycythemia vera. J Intern Med. 244:49–53. 1998.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Monge M, Vaida I, Modeliar SS, Solanilla
A, Airapetian N, Presne C, Makdassi R, Fournier A and Choukroun G:
Retroperitoneal hematoma compressing a single functioning kidney:
An unusual Cause of obstructive renal failure. Clin Nephrol.
67:318–320. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Cerquozzi S, Barraco D, Lasho T, Finke C,
Hanson CA, Ketterling RP, Pardanani A, Gangat N and Tefferi A: Risk
factors for arterial versus venous thrombosis in polycythemia vera:
A single center experience in 587 patients. Blood Cancer J.
7(662)2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Barbui T, Carobbio A, Rumi E, Finazzi G,
Gisslinger H, Rodeghiero F, Randi ML, Rambaldi A, Gisslinger B,
Pieri L, et al: In contemporary patients with polycythemia vera,
rates of thrombosis and risk factors delineate a new clinical
epidemiology. Blood. 124:3021–3023. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Plessier A, Darwish-Murad S,
Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J,
Morard I, Lasser L, Langlet P, et al: Acute portal vein thrombosis
unrelated to cirrhosis: A prospective multicenter follow-up study.
Hepatology. 51:210–218. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khanna R and Sarin SK: Non-cirrhotic
portal hypertension-diagnosis and management. J Hepatol.
60:421–441. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
European Association for the Study of the
Liver. Electronic address: simpleeasloffice@easloffice.eu.
EASL clinical practice guidelines: Vascular diseases of the liver.
J Hepatol. 64:179–202. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
de Franchis R: Baveno VI Faculty.
Expanding consensus in portal hypertension: Report of the Baveno VI
Consensus Workshop: Stratifying risk and individualizing care for
portal hypertension. J Hepatol. 63:743–752. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sarin SK, Sethi KK and Nanda R:
Measurement and correlation of wedged hepatic, intrahepatic,
intrasplenic and intravariceal pressures in patients with cirrhosis
of liver and non-cirrhotic portal fibrosis. Gut. 28:260–266.
1987.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Garcia-Pagan JC, Hernandez-Guerra M and
Bosch J: Extrahepatic portal vein thrombosis. Semin Liver Dis.
28:282–292. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sarin SK and Kumar A: Noncirrhotic portal
hypertension. Clin Liver Dis. 10:627–651, x. 2006.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Schouten JN, Garcia-Pagan JC, Valla DC and
Janssen HL: Idiopathic noncirrhotic portal hypertension.
Hepatology. 54:1071–1081. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Vollmar B and Menger MD: The hepatic
microcirculation: Mechanistic contributions and therapeutic targets
in liver injury and repair. Physiol Rev. 89:1269–1339.
2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Intagliata NM, Caldwell SH and Tripodi A:
Diagnosis, development, and treatment of portal vein thrombosis in
patients with and without cirrhosis. Gastroenterology.
156:1582–1599.e1. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649.
1973.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Llop E, de Juan C, Seijo S, Garcia-Criado
A, Abraldes JG, Bosch J and Garcia-Pagan JC: Portal cholangiopathy:
Radiological classification and natural history. Gut. 60:853–860.
2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Dhiman RK, Behera A, Chawla YK, Dilawari
JB and Suri S: Portal hypertensive biliopathy. Gut. 56:1001–1008.
2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Spencer RP and Pearson HA: The spleen as a
hematological organ. Semin Nucl Med. 5:95–102. 1975.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Noronha FC, Seijo S, Plessier A,
Silva-Junior G, Turon F, Rautou PE, Baiges A, Bureau C, Bosch J,
Hernandez-Gea V, et al: Natural history and management of
esophagogastric varices in chronic noncirrhotic, nontumoral portal
vein thrombosis. Hepatology. 63:1640–1650. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kovacs TOG and Jensen DM: Varices:
Esophageal, gastric, and rectal. Clin Liver Dis. 23:625–642.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Nagashima K, Irisawa A, Kashima K, Sakuma
F, Minaguchi T, Yamamiya A, Yamabe A, Hoshi K, Tominaga K, Iijima M
and Goda K: The risk of bleeding in small/straight esophageal
varices with red color sign on endoscopy: A retrospective analysis
from the natural course. Healthcare (Basel).
10(1193)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tefferi A, Vannucchi AM and Barbui T:
Polycythemia vera: Historical oversights, diagnostic details, and
therapeutic views. Leukemia. 35:3339–3351. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Latagliata R, Spadea A, Cedrone M, Di
Giandomenico J, De Muro M, Villiva N, Breccia M, Anaclerico B,
Porrini R, Spirito F, et al: Symptomatic mucocutaneous toxicity of
hydroxyurea in Philadelphia chromosome-negative myeloproliferative
neoplasms: The Mister Hyde face of a safe drug. Cancer.
118:404–409. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Bjornsson ES and Andrade RJ: Long-term
sequelae of drug-induced liver injury. J Hepatol. 76:435–445.
2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shepherd PC, Fooks J, Gray R and Allan NC:
Thioguanine used in maintenance therapy of chronic myeloid
leukaemia causes non-cirrhotic portal hypertension. Results from
MRC CML. II. Trial comparing busulphan with busulphan and
thioguanine. Br J Haematol. 79:185–192. 1991.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kim HP, Navarro V, Zacks S, Odin J,
Kleiner DE and Hayashi PH: Drug-Induced Liver Injury Network
Investigators. The clinical spectrum and diagnosis of oxaliplatin
liver injury in the era of nonalcoholic fatty liver disease. Clin
Gastroenterol Hepatol. 19:2199–2201. 2021.PubMed/NCBI View Article : Google Scholar
|
